Orlando, FL, August 18, 2020 –Therigy®, the trusted partner for specialty pharmacy therapy management software and services, announced today that Lily Duong, PharmD and Chief Clinical Officer, will present at the Vanderbilt Health-Systems Pharmacy Outcomes Research Summit on August 26. Dr. Duong will discuss “Health-System Collaborations in Outcome Research” as part of a panel along with Lana Gerzenshtein, PharmD, BCPS, CSP, from Excelera, and Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP, Vanderbilt University Medical Center.
Vanderbilt’s Outcomes Research Summit provides a forum for attendees to learn strategies to build outcomes research initiatives within a health-system specialty pharmacy and how to utilize research findings to portray value. During this summit, attendees will glean insight on partnering with key stakeholders (pharma, PBMs, technology partners, payers, etc.) in the industry to complete outcomes research projects. The summit is being held virtually this year and runs August 24-28, 2020.
Specialty pharmacies within health-systems are in the best position to provide quality care to specialty patients. Dr. Duong will share experiences in collaborative outcome initiatives amongst health-system specialty pharmacies. She will also address how collaborative outcomes initiatives can improve quality of care for specialty patients and will compare benefits of collecting patient clinical outcomes from multiple health-systems vs. a single health-system.
As Chief Clinical Officer for Therigy, Dr. Duong is responsible for the development of Therigy’s specialty therapy management program and clinical reporting. She provides clinical expertise and oversees the team that develops custom clinical and adherence programs as well as adherence metrics and outcomes reports for different patient populations and various disease states.
“On behalf of the entire Therigy team, we are honored to have Dr. Lily Duong present at this important specialty pharmacy summit,” said Joe Morse, President, Therigy. “The data and analysis that Dr. Duong will share will certainly be informative and actionable for health-system specialty pharmacy professionals and the patients they serve.”
Therigy® is a patient-focused specialty therapy management company. As an industry pioneer, Therigy continues to lead the specialty pharmacy market serving over one million active patients and eight thousand subscribers nationwide. Therigy equips pharmacy stakeholders with the tools to standardize and scale patient management programs—with a depth and consistency of clinical care never before possible—helping them to grow their patient population, deliver value-based outcomes, gain insights into evolving patient needs, and predict therapy trends. Learn more about Therigy at www.therigy.com.